Neogen Chemicals Limited — Investor Meet, 13-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** In Q2 FY25, Neogen Chemicals reported a 20% year-over-year increase in consolidated revenue, reaching ₹193.4 crore, driven by improved volumes and a contribution from acquisitions. EBITDA rose by 33% to ₹34.6 crore, while profit after tax saw a substantial 38% increase to ₹11 crore. Despite the challenging pricing environment, EBITDA margins remained healthy at 17.9%. On a standalone basis, revenue grew by 4% to ₹174.5 crore, with EBITDA increasing by 26% to ₹32.9 crore and PAT rising 43% to ₹13.1 crore.

2. **Future Outlook and Growth Drivers:** Management expressed optimism regarding growth in the battery materials segment through Neogen Ionics, focusing on lithium salts and electrolytes. Pending approvals from battery manufacturers and ongoing collaborative efforts are expected to enhance market penetration.

3. **Order Book and Operational Updates:** Expansion projects are progressing, particularly in battery chemicals, with plans to increase capacities in existing and new plants. Initial commercial sales from the Dahej facility have been promising.

4. **Analyst Q&A Insights (Detailed):**

- **Revenue and Profitability:** Analysts queried management regarding revenue growth sustainability amidst pricing pressures; management reaffirmed commitment to operational efficiency.

- **Market Position and Competitive Landscape:** Competitive threats from established players were discussed; management emphasized strategic collaborations to bolster market position.

- **Operational Challenges or Risks:** Supply chain issues related to lithium sourcing were acknowledged, yet management maintained confidence in their risk management strategies.

- **Capex and Capital Allocation:** Concerns over rising Capex in battery chemicals leading to increased depreciation were noted; management clarified these investments are crucial for future growth.

- **Strategic Priorities and Long-Term Vision:** Questions centered on innovation; management reiterated a strong R&D focus to drive product development.

5. **Market or Regulatory Updates:** The potential impact of global regulations encouraging non-Chinese supply chains was highlighted, emphasizing opportunities for Neogen in international markets.

6. **Strategic Focus Areas:** The company is prioritizing innovation, sustainable practices, and market expansion into high-tech chemical sectors, reflecting a strong growth strategy amid market fluctuations.

7. **Investor Insight:** The robust financial health and strategic direction indicate a favorable long-term outlook, suggesting a 'buy' stance considering Neogen's forward-thinking initiatives and market position.